A clinical trial to study the effects of Recombinant Human Erythropoietin therapy in management of anemia in patients suffering from Chronic Renal Failure.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Chronic Renal Failure
- Registration Number
- CTRI/2009/091/000786
- Lead Sponsor
- upin Limited India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Inclusion Criteria:
Patients of in the age group of 20-60 years
Patients with
ï??Haemoglobin < 10.0 gm/dl
ï??Hematocrit < 30 vol. %
Exclusion Criteria
Exclusion Criteria:
Patients suffering from superimposed uncontrolled infection or other active infection
Patient suffering from malignancy of bone marrow (leukemia)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method